Author
Listed:
- Deepak Bararia
(Cancer Science Institute, National University of Singapore
Dana Farber/Harvard Cancer Center
University Hospital of the Ludwig-Maximilians-University Munich
Experimentelle Leukämie-und Lymphomforschung (ELLF), LMU)
- Hui Si Kwok
(Cancer Science Institute, National University of Singapore
National University of Singapore Graduate School for Integrative Sciences and Engineering)
- Robert S. Welner
(Harvard Stem Cell Institute, Harvard Medical School
University of Alabama at Birmingham, Birmingham)
- Akihiko Numata
(Cancer Science Institute, National University of Singapore)
- Menyhárt B. Sárosi
(Institute of Inorganic Chemistry, Faculty of Chemistry and Mineralogy, Universität Leipzig)
- Henry Yang
(Cancer Science Institute, National University of Singapore)
- Sheena Wee
(Translational Biomedical Proteomics Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research)
- Sebastian Tschuri
(University Hospital of the Ludwig-Maximilians-University Munich
Experimentelle Leukämie-und Lymphomforschung (ELLF), LMU
German Cancer Consortium (DKTK)
German Cancer Research Center (DKFZ))
- Debleena Ray
(Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School)
- Oliver Weigert
(University Hospital of the Ludwig-Maximilians-University Munich
Experimentelle Leukämie-und Lymphomforschung (ELLF), LMU
German Cancer Consortium (DKTK)
German Cancer Research Center (DKFZ))
- Elena Levantini
(Dana Farber/Harvard Cancer Center
Harvard Stem Cell Institute, Harvard Medical School
Institute of Biomedical Technologies, National Research Council (CNR))
- Alexander K. Ebralidze
(Dana Farber/Harvard Cancer Center
Harvard Stem Cell Institute, Harvard Medical School)
- Jayantha Gunaratne
(Translational Biomedical Proteomics Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research
Yong Loo Lin School of Medicine, National University of Singapore)
- Daniel G. Tenen
(Cancer Science Institute, National University of Singapore
Dana Farber/Harvard Cancer Center
Harvard Stem Cell Institute, Harvard Medical School)
Abstract
CCAAT/enhancer-binding protein alpha (C/EBPα) is an essential transcription factor for myeloid lineage commitment. Here we demonstrate that acetylation of C/EBPα at lysine residues K298 and K302, mediated at least in part by general control non-derepressible 5 (GCN5), impairs C/EBPα DNA-binding ability and modulates C/EBPα transcriptional activity. Acetylated C/EBPα is enriched in human myeloid leukaemia cell lines and acute myeloid leukaemia (AML) samples, and downregulated upon granulocyte-colony stimulating factor (G-CSF)- mediated granulocytic differentiation of 32Dcl3 cells. C/EBPα mutants that mimic acetylation failed to induce granulocytic differentiation in C/EBPα-dependent assays, in both cell lines and in primary hematopoietic cells. Our data uncover GCN5 as a negative regulator of C/EBPα and demonstrate the importance of C/EBPα acetylation in myeloid differentiation.
Suggested Citation
Deepak Bararia & Hui Si Kwok & Robert S. Welner & Akihiko Numata & Menyhárt B. Sárosi & Henry Yang & Sheena Wee & Sebastian Tschuri & Debleena Ray & Oliver Weigert & Elena Levantini & Alexander K. Ebr, 2016.
"Acetylation of C/EBPα inhibits its granulopoietic function,"
Nature Communications, Nature, vol. 7(1), pages 1-13, April.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms10968
DOI: 10.1038/ncomms10968
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms10968. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.